Related Experiment Videos
Comment on "The End of Phase 3 Clinical Trials in Biosimilars Development?"
Christopher J Webster1, Gillian R Woollett2
1BioApprovals, Acton, MA, USA.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Analytical Data and Single-Dose PK are Sufficient to Conclude Comparable Immunogenicity for Biosimilars: An Ustekinumab Case Study.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2025
Surfacic networks.
PNAS nexus·2025
Future Evolution of Biosimilar Development by Application of Current Science and Available Evidence: The Developer's Perspective.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2023
The Role of PD Biomarkers in Biosimilar Development - To Get the Right Answer One Must First Ask the Right Question.
Clinical pharmacology and therapeutics·2022
Quantifying the embodied carbon saving potential of recycling construction and demolition waste in the Greater Bay Area, China: Status quo and future scenarios.
The Science of the total environment·2021
Comparability of Biologics: Global Principles, Evidentiary Consistency and Unrealized Reliance.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2021
Comparison of the Risk of Acute Anterior Uveitis Flare Between Adalimumab and Subcutaneous Infliximab in Patients with Radiographic Axial Spondyloarthritis and Prior Acute Anterior Uveitis: A Randomized Controlled Trial.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Targeting CD38 Across Autoimmune and Plasma Cell-Driven Immune-Mediated Diseases: Rationale, Clinical Evidence, and Emerging Therapeutic Landscape.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Clinical Outcomes After Week-12 Response-Guided Secukinumab Discontinuation in Psoriasis: A Prospective Real-World Cohort Study.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Population Pharmacokinetic Comparability of CT-P16 Versus EU-Avastin® and US-Avastin® in Healthy Subjects and Patients with Non-Squamous Non-Small Cell Lung Cancer.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Expanding Patient Access to Advanced Therapies.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Home Infusion With Recombinant Human α-Glucosidase in Children With Pompe Disease: The Dutch Experience Over 20 Years Across the Spectrum From Classic Infantile to Late-Onset Phenotypes.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Antidepressant effects of facial botulinum toxin a injections: Insights from randomized controlled trials.
Journal of affective disorders·2026
Long-term safety of steroid-sparing immunosuppression in uveitis.
Current opinion in ophthalmology·2026
Peritonitis and Mortality Risks of Gastric Acid Suppressants in Patients Undergoing Peritoneal Dialysis.
Kidney international reports·2026
Less Invasive Rapid Tranquilization in LMIC Emergency Settings: Comparison of Oral Risperidone Plus Clonazepam Versus Intramuscular Haloperidol in a Randomized Trial.
The International journal of social psychiatry·2026